Substantial revenues and earnings plus for Gerresheimer
Group revenues in the second quarter up by 6.8% (excluding Technical Plastic Systems) Further solid growth of the pharma business – improvement in the Cosmetics and Life Science Research segments Operating (Adjusted EBITDA) margin at high level of 20.9% Profit from operations more than doubled to EUR 24.8m Revenue guidance for 2010 specified and margin guidance raised